Ipamorelin 10mg

Description

Ipamorelin is a synthetic pentapeptide and a selective agonist of the ghrelin/growth hormone secretagogue receptor. It is recognized in clinical research for its ability to stimulate the anterior pituitary gland to release growth hormone (GH) without significantly affecting other hormones such as cortisol, prolactin, or ACTH. This high level of selectivity distinguishes it from earlier generations of GH-releasing peptides (GHRPs). Originally investigated for its potential in treating postoperative ileus and growth disorders, it is now a primary subject in studies concerning metabolic optimization and age-related physiological decline.

• Selective Secretagogue: Research demonstrates it triggers pulsatile GH release, mimicking natural biological rhythms more closely than synthetic HGH.
• Metabolic Impact: Studies indicate its role in promoting fat loss and improving muscle protein synthesis through elevated IGF-1 levels.
• Skeletal Health: Clinical data in animal models suggests it can counteract bone loss and increase longitudinal bone growth.
• Gastric Support: Investigations have explored its efficacy in accelerating gastric emptying and resolving symptoms of postoperative bowel dysfunction.